Literature DB >> 8572777

Determinants of early and late results of combined valve operations and coronary artery bypass grafting.

W J Flameng1, P Herijgers, J Szécsi, P T Sergeant, W J Daenen, I Scheys.   

Abstract

BACKGROUND: Factors determining the outcome of operative correction of valvular abnormalities combined with coronary artery bypass grafting are still incompletely defined.
METHODS: Determinants of early and late (more than 90 days) deaths and event-free survival were studied for combined valve operations and coronary artery bypass grafting in 741 patients using multivariate analysis.
RESULTS: Ninety-day survival probability was 89% (95% confidence interval, 87% to 92%). Preoperative risk factors for early death were age, female sex, renal failure, New York Heart Association class IV or V, and mitral insufficiency. The operative risk factor was the duration of aortic cross-clamping. Five- and 10-year survival probabilities were 74% (95% confidence interval, 71% to 78%) and 43% (95% confidence interval, 36% to 50%), respectively. Preoperative risk factors for late death were age, preoperative renal failure, New York Heart Association class IV or V, vessel disease, and nonsinus rhythm. Five- and 10-year event-free survival probabilities were 57% (95% confidence interval, 53% to 61%) and 23% (95% confidence interval, 17% to 28%), respectively. Preoperative risk factors for non-event-free survival were age, female sex, reduced left ventricular function, mitral regurgitation, and pacemaker rhythm.
CONCLUSION: The demographic factors of age and female sex; the comorbid condition of renal failure; the cardiac conditions of advanced New York Heart Association class, left ventricular function, mitral regurgitation, vessel disease, and cardiac rhythm; and the operative condition of ischemia time are the most important predictors of clinical outcome after combined valve operations and coronary artery bypass grafting.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8572777     DOI: 10.1016/0003-4975(95)00970-1

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  7 in total

Review 1.  Interface between valve disease and ischaemic heart disease.

Authors:  B Iung
Journal:  Heart       Date:  2000-09       Impact factor: 5.994

2.  Prediction of coronary artery disease in patients undergoing operations for rheumatic aortic valve disease.

Authors:  Tao Yan; Guan-xin Zhang; Bai-ling Li; Lin Han; Jia-jie Zang; Li Li; Zhi-yun Xu
Journal:  Clin Cardiol       Date:  2012-07-17       Impact factor: 2.882

3.  Surgical Approaches to Aortic Valve Replacement and Repair-Insights and Challenges.

Authors:  Basel Ramlawi; Mahesh Ramchandani; Michael J Reardon
Journal:  Interv Cardiol       Date:  2014-03

Review 4.  Available transcatheter aortic valve replacement technology.

Authors:  Dillon Weiss; Carlos E Ruiz; Luigi Pirelli; Vladimir Jelnin; Gregory P Fontana; Chad Kliger
Journal:  Curr Atheroscler Rep       Date:  2015-03       Impact factor: 5.113

5.  Long term survival after coronary endarterectomy in patients undergoing combined coronary and valvular surgery--a fifteen year experience.

Authors:  Sanjay Kumar; Sandeep Agarwala; Charlie Talbot; R Unnikrishnan Nair
Journal:  J Cardiothorac Surg       Date:  2008-03-26       Impact factor: 1.637

Review 6.  Diagnosis and Management of Cardiovascular Disease in Advanced and End-Stage Renal Disease.

Authors:  Navdeep K Bhatti; Keyvan Karimi Galougahi; Yehuda Paz; Tamim Nazif; Jeffrey W Moses; Martin B Leon; Gregg W Stone; Ajay J Kirtane; Dimitri Karmpaliotis; Sabahat Bokhari; Mark A Hardy; Geoffrey Dube; Sumit Mohan; Lloyd E Ratner; David J Cohen; Ziad A Ali
Journal:  J Am Heart Assoc       Date:  2016-08-04       Impact factor: 5.501

7.  Male-female differences in aortic valve and combined aortic valve/coronary surgery: a national cohort study in the Netherlands.

Authors:  M Mostafa Mokhles; Sadaf Soloukey Tbalvandany; Sabrina Siregar; Michel I M Versteegh; Luc Noyez; Bart van Putte; Alexander B A Vonk; Jolien W Roos-Hesselink; Ad J J C Bogers; Johanna J M Takkenberg
Journal:  Open Heart       Date:  2018-09-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.